A. Godard

G. Daculsi, S. Bohic, D. Heymann, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells.

J. Moreau, H. Gascan, J. Soulillou, 1988, Blood.

Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains.

M. Bonneville, H. Vié, A. Necker, 1997, Journal of immunology.

Presence of leukaemia inhibitory factor and interleukin 6 in porcine uterine secretions prior to conceptus attachment.

I. Anegon, J. Soulillou, M. Cuturi, 1994, Cytokine.

A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.

J. Soulillou, Y. Jacques, B. Le Mauff, 1987, Journal of immunology.

Presence of leukaemia inhibitory factor (LIF) and LIF-receptor chain (gp190) in osteoclast-like cells cultured from human giant cell tumour of bone. Ultrastructural distribution.

D. Heymann, M. Cottrel, F. Gouin, 1999, Cytokine.

Epitope-function relationships of human leukemia inhibitory factor receptors using a novel set of anti-gp190 mAB.

M. Hallet, J. Taupin, F. Blanchard, 1997, International immunology.

Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells

B. Dréno, F. Blanchard, Y. Jacques, 2009, The Journal of pathology.

Relationship between responsiveness of cancer cells to Oncostatin M and/or IL‐6 and survival of stage III melanoma patients treated with tumour‐infiltrating lymphocytes

B. Dréno, A. Khammari, F. Blanchard, 2008, The Journal of pathology.

Increased levels of leukaemia inhibitory factor (LIF) in urine and tissue culture supernatant from human primary bone tumours.

G. Daculsi, D. de Groote, D. Heymann, 1998, Cytokine.

Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues.

V. Praloran, H. Gascan, I. Anegon, 1990, Journal of immunology.

FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins

H. Baumann, W. Held, B. Asch, 2002, Oncogene.

Lymphocyte subsets, phytohaemagglutinin responsiveness of blood lymphocytes, and interleukin 2 production in sarcoidosis.

J. Soulillou, J. Bignon, A. Godard, 1985, Thorax.

Reconstitution of two isoforms of the human interleukin-11 receptor and comparison of their functional properties.

P. Heinrich, G. Müller-Newen, M. Hallet, 1997, FEBS letters.

Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190.

A. Vernallis, J. Taupin, F. Blanchard, 1997, Journal of immunological methods.

Abnormal production of interleukin (IL)-11 and IL-8 in polycythaemia vera.

E. Lippert, S. Hermouet, Y. Jacques, 2002, Cytokine.

Stimulation of Leukemia Inhibitory Factor Receptor Degradation by Extracellular Signal-regulated Kinase*

H. Baumann, F. Blanchard, Yanping Wang, 2000, The Journal of Biological Chemistry.

Expression of leukemia inhibitory factor by cartilage‐forming tumors of bone: An immunohistochemical study

D. Heymann, A. Moreau, F. Gouin, 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Regulation of interleukin 2 receptor expression on a human cytotoxic T lymphocyte clone, synergism between alloantigenic stimulation and interleukin 2.

D. Olive, J. Moreau, J. Soulillou, 1986, Journal of immunology.

Preparative two-step purification of human IL-2 by HPLC and hydrophobic affinity chromatography.

H. Vié, J. Moreau, J. Soulillou, 1984, Journal of immunological methods.

T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.

M. Bonneville, J. Moreau, J. Soulillou, 1986, The Journal of clinical investigation.

Impaired IL2 production by lymphocytes of patients with systemic lupus erythematosus.

J. Moreau, J. Soulillou, P. de Faucal, 1984, Annales d'immunologie.

Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells.

V. Praloran, Y. Denizot, S. Raher, 2000, Cytokine.

Binding of Leukemia Inhibitory Factor (LIF) to Mutants of Its Low Affinity Receptor, gp190, Reveals a LIF Binding Site Outside and Interactions between the Two Cytokine Binding Domains*

S. Daburon, J. Moreau, J. Taupin, 1999, The Journal of Biological Chemistry.

Leukaemia inhibitory factor (LIF) production in pleural effusions: comparison with production of IL-4, IL-8, IL-10 and macrophage-colony stimulating factor (M-CSF).

V. Praloran, E. L’her, D. de Groote, 1996, Cytokine.

Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis.

D. Villers, D. de Groote, I. Anegon, 1995, The Journal of infectious diseases.

High and Low Affinity Receptors for Human Interleukin for DA Cells / Leukemia Inhibitory Factor on Human Cells

I. Anegon, D. Heymann, J. Soulillou, 2001 .

Upmodulation of multinucleated cell formation in long-term human bone marrow cultures by leukaemia inhibitory factor (LIF).

G. Daculsi, D. Heymann, F. Gouin, 1997, Cytokine.

High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution.

I. Anegon, D. Heymann, J. Soulillou, 1992, The Journal of biological chemistry.

Oncostatin M Regulates the Synthesis and Turnover of gp130, Leukemia Inhibitory Factor Receptor α, and Oncostatin M Receptor β by Distinct Mechanisms*

H. Baumann, F. Blanchard, Yanping Wang, 2001, The Journal of Biological Chemistry.

Loss of oncostatin M receptor β in metastatic melanoma cells

B. Dréno, A. Khammari, F. Blanchard, 2007, Oncogene.

Culturing of cells from giant cell tumour of bone on natural and synthetic calcified substrata: the effect of leukaemia inhibitory factor and vitamin D3 on the resorbing activity of osteoclast-like cells

O. Gan, G. Daculsi, D. Heymann, 2004, Virchows Archiv.

Reconstitution of two isoforms of the human interleukin‐11 receptor and comparison of their functional properties

P. Heinrich, G. Müller-Newen, M. Hallet, 1997 .

Lipid mediators modulate the synthesis of interleukin 8 by human bone marrow stromal cells.

V. Praloran, Y. Denizot, S. Raher, 1999, Cytokine.

Mutations in the Immunoglobulin-like Domain of gp190, the Leukemia Inhibitory Factor (LIF) Receptor, Increase or Decrease Its Affinity for LIF*

Yannick Jacques, Frédéric Blanchard, John K Heath, 2003, The Journal of Biological Chemistry.

Biochemical study of a recombinant soluble interleukin-2 receptor. Evidence for a homodimeric structure.

J. Soulillou, H. Marsh, Y. Jacques, 1990, The Journal of biological chemistry.

Leukaemia inhibitory factor expression in human follicular fluid.

P. Barrière, P. Lopes, M. Jean, 1999, Human Reproduction.

Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II.

Yannick Jacques, Benjamin Chaigne-Delalande, Frederic Blanchard, 2003, Endocrinology.

Leukaemia Inhibitory Factor derived from rat colon carcinoma cells increases host susceptibility to tumour growth.

J. Le Pendu, L. Tesson, I. Anegon, 1995, Cytokine.

Loss of oncostatin M receptor beta in metastatic melanoma cells.

B. Dréno, A. Khammari, F. Blanchard, 2007, Oncogene.

An ELISA for the measurement of human leukemia inhibitory factor in biological fluids and culture supernatants.

M. Jadoul, D. de Groote, P. Franchimont, 1994, Journal of immunological methods.

High titre anticytokine antibodies obtained by intralymphnode immunization with low amounts of antigen.

V. Praloran, A. Godard, L. Coupey, 1993, Cytokine.

Subunit structure of the high and low affinity human interleukin-15 receptors.

S. Dubois, Y. Jacques, S. Raher, 2000, European cytokine network.

Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.

M. Hallet, D. Heymann, F. Blanchard, 1996, Cytokine.

[Modulation of integrin alpha-v-beta-1 expression on human tumor cells by leukemia inhibitory factor (LIF) and oncostatin M (OSM)].

D. Heymann, J. Harb, F. Blanchard, 1996, Bulletin du cancer.